{"id":222852,"date":"2026-08-31T10:30:27","date_gmt":"2026-08-31T05:00:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=222852"},"modified":"2026-08-31T10:30:29","modified_gmt":"2026-08-31T05:00:29","slug":"symbiotec-pharmalab-initial-public-offering-listing-preview-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/symbiotec-pharmalab-initial-public-offering-listing-preview-2026\/","title":{"rendered":"Symbiotec Pharmalab Listing Preview: Shares Debut Tomorrow After 75.08x Subscription, QIB Demand Tops 181x"},"content":{"rendered":"
<\/div>\n

Symbiotec Pharmalab lists on NSE, BSE tomorrow, Sep 1, 2026. Final subscription 75.08x: QIB 181.20x, NII 77.56x, retail 13.69x. Allotment finalized Aug 28.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Symbiotec Pharmalab shares are scheduled to list on the NSE and BSE tomorrow, September 1, 2026, after the Rs 1,757 crore initial public offering closed with a final subscription of 75.08 times. The qualified institutional buyer (QIB) category led demand at 181.20 times, followed by non-institutional investors at 77.56 times and retail investors at 13.69 times.<\/p>\n<\/div>\n

Symbiotec Pharmalab Limited’s shares are scheduled to list on the NSE and BSE tomorrow, September 1, 2026, following the close of its Rs 1,757 crore initial public offering on August 27, 2026. The issue received a final overall subscription of 75.08 times, with the qualified institutional buyer (QIB) category recording the strongest demand at 181.20 times, followed by non-institutional investors at 77.56 times and retail investors at 13.69 times.<\/p>\n

The basis of allotment was finalised on August 28, 2026, with shares credited to successful applicants’ demat accounts by August 31, 2026, ahead of tomorrow’s listing.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n